SL Science Holding Ltd (NASDAQ: SLBT) is a Healthcare company (Biotechnology) with a market capitalization of $356M. The Maz Rating grades it against the other companies in its sector.
SL Science Holding Ltd's current Maz Rating and its five factor grades are for members: log in to see them.
At $0.64, SL Science Holding Ltd trades at 169.3x sales. Over the last twelve months it generated about $2M of revenue. It runs a gross margin of 35.3%, an operating margin of -174.6% and a net margin of -173.8%. It shows return on equity of -95.4%, return on invested capital of -153.7% and a free cash flow yield of -0.6%. On the balance sheet: a debt-to-equity ratio of 0.09 and a current ratio of 3.05. Over the past 52 weeks the share price ranged from $0.62 to $14.50, with a beta of 0.09.
SL Science Holding Ltd does not currently pay a dividend.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.